Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Coroller, Thibaud P ^a,b,d   Mak, Raymond H ^a,b   Lewis, John H ^a,b   Baldini, Elizabeth H ^a,b   Chen, Aileen B ^a,b   Colson, Yolonda L ^a,b   Hacker, Fred L ^a,b   Hermann, Gretchen ^a   Kozono, David ^a,b   Mannarino, Edward ^a   Molodowitch, Christina ^a   Wee, Jon O ^a,b   Sher, David J ^c   Killoran, Joseph H ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIMARY TUMOR; RADIATION DOSE FRACTIONATION; RADIATION DOSE REDUCTION; RADIATION INJURY; RADIATION SAFETY; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; THORAX WALL; TREATMENT PLANNING; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CHEST PAIN; COMPLICATION; INCIDENCE; LUNG NEOPLASMS; METASTASIS; MIDDLE AGED; RADIATION DOSE; RADIOGRAPHY; RADIOMETRY; RADIOSURGERY; RIB FRACTURES; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEST PAIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIATION DOSAGE; RADIOMETRY; RADIOSURGERY; RIB FRACTURES; RISK FACTORS; THORACIC WALL;

EID: 84899628481     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094859     Document Type: Article

References (19)

1. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, et al. (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101(7): 1623-1631. (Pubitemid 39318910)
2. Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, et al. (2011) Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 28(6): 928-935.
3. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senean S (2012) Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage nonsmall-cell lung cancer: a retrospective analysis. Lancet Oncol 13(8): 802-809.
4. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, et al. (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24(30): 4833-4839. (Pubitemid 46630909)
5. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, et al. (2009) Outcome in a prospective phase II trial of medically inoperable stage I nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27(20): 3290-3296.
6. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, et al. (2013) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11): 1070-1076.
7. Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, et al. (2010) Chest wall volume receiving .30Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol 76(3): 796-801.
8. Stephans KL, Djemil T, Tendulkar RD, Robinson CG, Reddy CA, et al. (2012) Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT). Int J Radiat Oncol Biol 82(2): 974-980.
9. Woody NM, Videtic GMM, Stephans KL, Djemil T, Kim Y, et al. (2012) Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes. Int J Radiat Oncol Biol 83(1): 427-434.
10. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S (2008) Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol 70(3): 685-692.
11. Pettersson N, Nyman J, Johanson KA (2009) Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose-and volume-reponse analysis. Radiother Oncol 91(3): 360-368.
12. Andolino DL, Forquer JA, Henderson MA, Barriger RB, Shapiro RH, et al. (2011) Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. Int J Radiat Oncol Biol 80(3): 692-697.
13. Welsh J, Thomas J, Shah D, Allen PK, Wei X, et al. (2011) Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int J Radiat Oncol Biol 81(1): 91-96.
14. Bongers EM, Haasbeek CJA, Lagerwaard FJ, Slotman BJ, Senan S (2011) Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer. J Thorac Oncol 6(12): 2052-2057.
15. Stephans KL, Djemil T, Reddy CA, Gajdos SM, Kolar M, et al. (2009) A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer. J Thorac Oncol 4(8): 976-982.
16. Videtic GM, Stephans KL (2010) The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep 12(4): 235-241.
17. Park CS, Kim Y, Lee N, Bucci KM, Quivey JM, et al. (2005) Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose. Int J Radiat Oncol Biol 62(3): 925-932. (Pubitemid 40779788)
18. Kutcher GJ, Burman C (1989) Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol biol Phys 16(6): 1623-1630. (Pubitemid 19154353)
19. Xiao Y, Papiez L, Paulus R, Timmerman R, Straube WL, et al. (2009) Dosimetric evaluation of heterogeneity corrections for RTOG 0236: Stereotactic Body Radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol biol Phys 73(4): 1235-1242.